Abstract:The Fragile X Messenger Ribonucleoprotein (FMRP) is a selective RNA-binding protein that localizes to the cytoplasm and the nucleus. The loss of FMRP results in Fragile X Syndrome (FXS), an Autism Spectrum Disorder. FMRP interacts with ribosomes and regulates the translation of mRNAs essential for neuronal development and synaptic plasticity. However, the biochemical nature of this translation regulation is unknown. Here we report that a key feature of FMRP-mediated translation regulation during neuronal differentiation is modulating the 2'O-methylation of ribosomal RNA. 2'O-methylation, facilitated by C/D box snoRNAs in the nucleus, is a major epitranscriptome mark on rRNA, essential for ribosome assembly and function. We found that FMRP influences a distinct rRNA 2'O-Methylation pattern across neuronal differentiation. We show that in H9 ESCs, FMRP interacts with a selected set of C/D box snoRNA in the nucleus resulting in the generation of ribosomes with a distinct pattern of rRNA 2'O-Methylation. This epitranscriptome pattern on rRNA undergoes a significant change during the differentiation of ESCs to neuronal precursors and cortical neurons. ESCs display maximum hypomethylated residues on rRNA, which is eventually reduced in neuronal precursors and post-mitotic cortical neurons and this is correlated to the change in global protein synthesis among the states of differentiation. Importantly, this gradual change in the 2'O-methylation pattern during neuronal differentiation is altered in the absence of FMRP, which could impact neuronal development and contribute to dysregulated protein synthesis observed in Fragile X Syndrome. This also suggests the need for diversity in functional ribosomes during the early stages of development.

The RNA-binding protein FMRP facilitates the nuclear export of N6-methyladenosine–containing mRNAs

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

A noncanonical RNA-binding domain of the fragile X protein, FMRP, elicits translational repression independent of mRNA G-quadruplexes

N-6-methyladenosine (m6A) Promotes the Nuclear Retention of mRNAs with Intact 5' Splice Site Motifs

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

FMRP inhibits translation elongation independent of mRNA G-quadruplexes

Altering rRNA 2'O-methylation pattern during neuronal differentiation is regulated by FMRP

Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP

N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein

N 6 -methyladenosine-dependent regulation of messenger RNA stability

N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

FMRP Long-Range Transport and Degradation Are Mediated by Dynlrb1 in Sensory Neurons

The FMRP–MOV10 complex: a translational regulatory switch modulated by G-Quadruplexes

The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain

FMRP phosphorylation modulates neuronal translation through YTHDF1

N-6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation

FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation

FMRP links optimal codons to mRNA stability in neurons

Ribosomes in RNA granules are stalled on mRNA sequences that are consensus sites for FMRP association